Such in vivo findings were reinforced by in vitro findings in a panel of eight ovarian cancer cell lines where the three AZD compounds inhibited the Akt downstream effectors, 4E-BP1 and p70S6 kinase. This evidence concerns the gene AKT1 and ovarian carcinoma.